Paper985152
Adjuvant nitrosourea therapy for glioblastoma.
Brisman R and 4 others. Arch Neurol, 1976. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Adjuvant nitrosourea therapy for glioblastoma. Papers, record 985152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/985152
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Carmustine | Major topic |
| Glioma | Major topic |
| Lomustine | Major topic |
| Nitrosourea Compounds | Major topic |
| Semustine | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Child | |
| Child, Preschool | |
| Drug Evaluation | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37371674 | Personalized Treatment of Glioblastoma: Current State and Future Perspective. | Biomedicines | 2023 | https://conductscience.org/library/papers/37371674 | PubMed |
| 35626024 | Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go? | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35626024 | PubMed |
| 32202316 | Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32202316 | PubMed |
| 12519620 | Chemotherapy for high-grade glioma. | Cochrane Database Syst Rev | 2002 | https://conductscience.org/library/papers/12519620 | PubMed |
| 3620320 | An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma. | Br J Cancer | 1987 | https://conductscience.org/library/papers/3620320 | PubMed |
| 2213115 | Prognostic factors for high-grade malignant glioma: development of a prognostic index. A Report of the Medical Research Council Brain Tumour Working Party. | J Neurooncol | 1990 | https://conductscience.org/library/papers/2213115 | PubMed |
| 532722 | Combination chemotherapy (COMP protocol) and radiotherapy of anaplastic supratentorial gliomas. | Acta Neurochir (Wien) | 1979 | https://conductscience.org/library/papers/532722 | PubMed |
| 468898 | Brain tumor chemotherapy using a rat glioma model. | J Cancer Res Clin Oncol | 1979 | https://conductscience.org/library/papers/468898 | PubMed |
| 211808 | Glioblastoma multiforme: morphology and biology. | Acta Neurochir (Wien) | 1978 | https://conductscience.org/library/papers/211808 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/985152
GET https://conductscience.org/api/papers/v1/985152/authors